BiotechTube
Home/Amorphex Therapeutics/Charles Leahy
CL

Charles Leahy

Vice President, Clinical Affairs

Amorphex Therapeutics

Therapeutic Areas

OphthalmologyGlaucomaRetinal DiseasesMyopia

Amorphex Therapeutics Pipeline

DrugIndicationPhase
TODDD™ PlatformGlaucomaPre-clinical

Leadership Team at Amorphex Therapeutics

RT
Robert Thompson
President & CEO
View full Amorphex Therapeutics profile